Cost-effectiveness analysis of endoscopic sinus surgery versus external approach for sinonasal inverted papilloma
Publication: Journal of Comparative Effectiveness Research
Abstract
Aim: Sinonasal inverted papilloma is a benign yet locally aggressive tumor with potential for recurrence. Surgical resection is the primary treatment, and both endoscopic sinus surgery (ESS) and external approaches are employed depending on tumor location and stage. While clinical outcomes of both techniques have been studied, their economic implications remain underexplored. Materials & methods: A retrospective cost-effectiveness analysis was conducted on 50 patients treated for histologically confirmed inverted papilloma between 1995 and 2018. Patients underwent either ESS or an external approach. Direct medical costs were calculated from hospital records, and effectiveness was measured by 5-year disease-free survival (DFS). Cost-minimization and cost-effectiveness analyses were performed, including subgroup evaluation by Krouse stage. Results: The median total cost was significantly lower for the endoscopic group (€7567.23) compared with the external group (€11,456.40; p = 0.018). Endoscopic surgery resulted in an average savings of approximately €4000 per patient over a 5-year period. In localized disease tumors (Krouse I–II), ESS was both less costly and equally effective. Although the external approach showed a slightly higher DFS (77.2 vs 67.8%), the incremental cost-effectiveness ratio (ICER) was €40,837.13, suggesting limited cost-justification for this benefit. Conclusion: Endoscopic surgery resulted in an average saving of approximately €4000 per patient over a 5-year period. While external approaches showed slightly better disease-free survival, the endoscopic technique proved significantly more cost-effective, offering a better balance between clinical outcomes and resource use.
Plain language summary
What is this article about?
This study compares two surgical techniques used to treat a rare nasal tumor called inverted papilloma. The two techniques are: endoscopic sinus surgery, which is minimally invasive and performed through the nose, and external surgery, which requires an incision on the face. We wanted to find out which method is more cost-effective, meaning which offers better value by balancing results and expenses.
What were the results?
We studied 50 patients treated at a single hospital. We found that the endoscopic technique was significantly less expensive, saving about €4000 per patient over 5 years, compared with the external approach. While the external surgery had a slightly higher tumor control rate (77 vs 68%), it also involved longer hospital stays and higher overall costs.
What do the results mean?
The endoscopic approach is more cost-effective in most cases, especially in patients with localized-stage tumors. These results support using the endoscopic method as the first choice when technically possible. Understanding the economic impact of each technique can help hospitals and surgeons make better decisions that balance clinical outcomes with responsible healthcare spending.
Formats available
You can view the full content in the following formats:
References
Papers of special note have been highlighted as: • of interest; •• of considerable interest
1.
Lawson W, Schlecht NF, Brandwein-Gensler M. The role of the Schneiderian membrane in the pathogenesis of sinonasal papillomas. Laryngoscope 118(2), 291–296 (2008).
2.
Hunt JL, el-Naggar A, Slootweg PJ, Chan JKC. Sinonasal papilloma, inverted type. In: WHO Classification of Tumors: Head and Neck. IARC Press, Paris, France, 18–19 (2017).
3.
Vrabec DP. The inverted Schneiderian papilloma: a 25-year study. Laryngoscope 104(5 Pt 1), 582–587 (1994).
4.
Nudell J, Chiosea S, Thompson LDR. Carcinoma ex-Schneiderian papilloma (malignant transformation): a clinicopathologic and immunophenotypic study of 20 cases combined with a comprehensive review of the literature. Head Neck Pathol. 8(3), 269–286 (2014).
5.
Bishop JA. OSPs and ESPs and ISPs, Oh My! An update on sinonasal (Schneiderian) papillomas. Head Neck Pathol. 11(3), 269–277 (2017).
6.
Sham CL, Woo JK, van Hasselt CA. Endoscopic resection of inverted papilloma of the nose and paranasal sinuses. J. Laryngol. Otol. 112(8), 758–764 (1998).
7.
Kamel RH. Endoscopic medial maxillectomy: a minimally invasive approach for maxillary sinus pathology. J. Laryngol. Otol. 124(4), 400–404 (2010).
8.
Castelnuovo P, Dallan I, Locatelli D et al. Endoscopic management of sinonasal malignancies: 10-year experience. Am. J. Rhinol. Allergy 25(3), 208–216 (2011).
9.
Busquets JM, Hwang PH. Endoscopic resection of sinonasal inverted papilloma: a meta-analysis. Otolaryngol. Head Neck Surg. 134(3), 476–482 (2006).
10.
Sun W, Zhang Y, Li S, Xu X, Xu G. Endoscopic medial maxillectomy: indications, technique, and outcomes. Am. J. Otolaryngol. 42(3), 102920 (2021).
11.
Bhattacharyya N. Endoscopic resection of sinonasal inverted papilloma: systematic review and meta-analysis. Otolaryngol. Head Neck Surg. 164(1), 16–24 (2021).
•• This meta-analysis is a cornerstone reference supporting the superior recurrence outcomes of endoscopic resection in sinonasal inverted papilloma (IP).
12.
Geiger G, Thomann I, Wellenstein D, Plettenberg A, Vogl TJ, Knoop H. Endoscopic sinus surgery in frontal sinus inverted papilloma: a systematic review. J. Pers. Med. 15(2), 183 (2025).
13.
Kim DY, Lee SH, Cho JH, Chung YS. Endoscopic versus external resection of sinonasal inverted papilloma: meta-analysis. Egypt. J. Otolaryngol. 38(1), 71 (2022).
• Highlights comparative effectiveness between surgical techniques, reinforcing the study’s rationale.
14.
Sauter A, Matharu R, Hörmann K, Naim R. Current advances in the basic research and clinical management of sinonasal inverted papilloma. Oncol. Rep. 17, 495–504 (2007).
15.
Lombardi D, Tomenzoli D, Butta L, Bizzoni A, Farina D, Nicolai P. Limitations and complications of endoscopic surgery for treatment of sinonasal inverted papilloma: a reassessment after 212 cases. Head Neck 33, 1154–1161 (2011).
16.
Sacristán JA, Ortún V, Rovira J, Prieto L, García Alonso F. Evaluación económica en medicina. Med. Clin. (Barc) 122(10), 379–382 (2004).
17.
Diaz-de-Cerio P, Preciado J, Santaolalla F, Sanchez-Del-Rey A. Cost-minimisation and cost-effectiveness analysis comparing transoral CO2 laser cordectomy, laryngofissure cordectomy and radiotherapy for the treatment of T1-2, N0, M0 glottic carcinoma. Eur. Arch. Otorhinolaryngol. 270(4), 1181–1188 (2013).
18.
Adamiak G. Methods for the economic evaluation of health care programmes, 3rd ed. J. Epidemiol. Community Health 60(9), 822–823 (2006).
19.
Martínez MM, Bosco G, Amarillo E et al. Eficacia del tratamiento quirúrgico del papiloma invertido nasosinusal. Rev. ORL 13(4), 277–287 (2022).
• Provides a recent Spanish-language analysis on surgical efficacy for sinonasal IP, supporting regional context.
20.
Ohki M, Kikuchi S. Sinonasal inverted papilloma: efficacy of demucosation to reduce recurrence after surgical managements. Indian J. Otolaryngol. Head Neck Surg. 71(Suppl. 3), 2186–2193 (2019).
21.
Caulley L, Rodin D, Kilty S, Randolph G, Hunink MG, Shin JJ. Evidence-based medicine in Otolaryngology part 10: cost-effectiveness analyses in Otolaryngology. Otolaryngol. Head Neck Surg. 161(3), 375–387 (2019).
•• Key reference for understanding the role and methodology of cost-effectiveness in ear, nose and throat surgical interventions.
22.
Pinto Prades JL, Sánchez Martínez FI. Métodos para la evaluación económica de nuevas prestaciones. Ministerio de Sanidad y Consumo, Madrid, Spain (2003).
23.
Prieto L, Sacristán JA, Antoñanzas F, Rubio-Terrés C, Pinto JL, Rovira J. Análisis coste-efectividad en la evaluación económica de intervenciones sanitarias. Med. Clin. 122(13), 505–510 (2004).
24.
Rudmik L. Health economics in rhinology: cost-effectiveness analyses in chronic rhinosinusitis and beyond. Curr. Opin. Otolaryngol. Head Neck Surg. 22(3), 231–236 (2014).
•• Provides a conceptual framework for economic analysis in rhinology, applicable to studies comparing surgical interventions.
25.
Bhattacharyya N, Orlandi RR, Grebner J, Martinson M. Cost burden of chronic rhinosinusitis: a claims-based study. Otolaryngol. Head Neck Surg. 144(3), 440–445 (2011).
• Supports external cost comparisons and underscores the economic relevance of sinonasal procedures.
26.
Au J, Rudmik L. Cost of outpatient endoscopic sinus surgery from the perspective of the Canadian government: a time-driven activity-based costing approach. Int. Forum Allergy Rhinol. 3(9), 748–754 (2013).
• Provides international costing benchmarks for endoscopic sinus surgery (ESS), useful for comparative interpretation.
27.
Ge W, Wang D, Chuang CC et al. Real-world cost of nasal polyps surgery and risk of major complications in the United States: a descriptive retrospective database analysis. Clinicoecon. Outcomes Res. 15, 209–211 (2023).
• A large-scale, recent cost analysis offering critical insights into ESS outcomes and complications.
28.
Bhattacharyya N, Villeneuve S, Joish VN et al. Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope 129(9), 1969–1975 (2019).
• Adds perspective on economic burden and healthcare utilization for chronic nasal disease, contextualizing the importance of surgical cost-efficiency.
Information & Authors
Information
Published In
Copyright
© 2025 The authors. This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License
History
Received: 28 June 2025
Accepted: 27 August 2025
Published online: 1 October 2025
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
Cost-effectiveness analysis of endoscopic sinus surgery versus external approach for sinonasal inverted papilloma. (2025) Journal of Comparative Effectiveness Research. DOI: 10.57264/cer-2025-0109
Export citation
Select the citation format you wish to export for this article or chapter.
